EARNINGS · MONDAY, NOVEMBER 16
Earnings reports — November 16, 2026
124 US companies filed quarterly results with the SEC (8-K Item 2.02). We read 57 and called the likely one-week price move. Calls are graded in the open.
WYY08:17 ETneutral
WIDEPOINT CORP (WYY) quarterly results
The company reported increased revenues and managed costs despite headwinds, including delays in the CWMS 3.0 procurement, but the outcome of the CWMS 3.0 award is still pending and may impact future results. The filing does not contain a quantified surprise, such as an earnings or guidance beat, or a confirmed takeover at a premium.
OUR ANALYSIS → VIEW 8-K →
FFAI17:00 ETnegative
FARADAY FUTURE INTELLIGENT ELECTRIC INC. (FFAI) quarterly results
Faraday Future reported Q3 revenue of $1.15 million and a narrowed net loss of $9.8 million, with its robotics business generating $2.3 million in cumulative revenue, but the stock's recent 76.7% decline over the past month may indicate ongoing investor concerns despite the improved financials.
OUR ANALYSIS → VIEW 8-K →
NFE09:03 ETneutral
New Fortress Energy Inc. (NFE) quarterly results
The company's debt principal was reduced from $5.7 billion to $0.7 billion, and it reported net income of $863.4 million in the third quarter of 2026, driven by non-cash gains on restructuring and extinguishment of debt. However, there is substantial doubt about the company's ability to continue as a going concern due to the timing of FLNG 1's return to service being outside of its control.
OUR ANALYSIS → VIEW 8-K →
VTIX08:15 ETpositive
Virtuix Holdings Inc. (VTIX) quarterly results
Virtuix reports 105% Omni One revenue growth and a 3.3X increase in Omni One unit orders, with total quarterly revenue rising 55% sequentially to $1.2 million, and announces a non-binding letter of intent to acquire STS International for approximately $12 million, which could expand its presence in the defense market.
OUR ANALYSIS → VIEW 8-K →
VENU08:00 ETneutral
Venu Holding Corp (VENU) quarterly results
Venu Holding Corp reported a 59% increase in total assets to $587.6 million and a 70% increase in property and equipment to $519.8 million, with Luxe FireSuite and Aikman Club sales reaching over $300 million, but the stock's move will depend on how investors weigh these growth metrics against the costs of bringing new assets online
OUR ANALYSIS → VIEW 8-K →
GALT07:55 ETneutral
GALECTIN THERAPEUTICS INC (GALT) quarterly results
The company reported financial results and provided a business update, including progress on its belapectin program, but there are no quantified surprises or significant updates that would indicate a substantial impact on the stock price. The submission of the registrational Phase 3 protocol to FDA and the presentation of new analyses at AASLD are positive developments, but they are likely already
OUR ANALYSIS → VIEW 8-K →
CEPL16:54 ETneutral
Capstone Energy Plus, Inc. (CEPL) quarterly results
The company's $25 million refinancing agreement with Monarch Alternative Capital LP and 11% increase in parts and services revenue are positive, but the net loss of $4.0 million and lower rental utilization are concerning. The debt refinancing may provide some relief, but the overall financial performance is still under pressure.
OUR ANALYSIS → VIEW 8-K →
RSSS16:19 ETpositive
Research Solutions, Inc. (RSSS) quarterly results
Research Solutions, Inc. reported an 11.5% year-over-year increase in B2B ARR and a 5.7% increase in total ARR, with net income of $765,000 or $0.02 per diluted share, driven by the continued platform mix shift and improved transaction margins.
OUR ANALYSIS → VIEW 8-K →
PHUN12:15 ETneutral
Phunware, Inc. (PHUN) quarterly results
Phunware reported a 61.2% increase in gross profit and a 56.7% gross margin for the third quarter, with $86.7 million in cash and no debt, but revenue growth was modest at 8.3% and the company is still investing heavily in product development and sales efforts.
OUR ANALYSIS → VIEW 8-K →
HCWB08:30 ETnegative
HCW Biologics Inc. (HCWB) quarterly results
The company reported financial results and recent business highlights, including raising $8.6 million in equity financing and securing up to $10.0 million in debt financing, but the filing lacks a significant quantified surprise to drive a positive impact, and the recent capital raise could lead to dilution, which is typically negative for the stock price, especially considering the micro-cap natu
OUR ANALYSIS → VIEW 8-K →
RENX08:30 ETpositive
RenX Enterprises Corp. (RENX) quarterly results
RenX Enterprises Corp. reported record third quarter revenue of $4.48 million, up 27.5% year over year, with gross margin expanding to 34.3% and the Logistics segment posting its third consecutive quarter of operating profitability. However, the company still reported a net loss of $8.7 million, and the cash position was relatively weak at $0.2 million.
OUR ANALYSIS → VIEW 8-K →
LNZA07:52 ETneutral
LanzaTech Global, Inc. (LNZA) quarterly results
LanzaTech reported a net loss of $178 million, primarily due to a non-cash unrealized fair value loss on its investment in SGLT, but showed improvement in operating expenses and adjusted EBITDA loss, and achieved the world's first ISCC EU certification for recycled carbon fuels from steel mill waste gases, opening a path to profit potential in European fuel markets
OUR ANALYSIS → VIEW 8-K →
BDCO16:18 ETpositive
BLUE DOLPHIN ENERGY CO (BDCO) quarterly results
Blue Dolphin Energy reported a strong quarter with total gross profit of $26.5 million and net income of $18.9 million, or $1.27 per share, driven by favorable gross margins from the refining segment, and also showed significant improvement in cash flow from operations, which increased by $56.9 million compared to the same period last year.
OUR ANALYSIS → VIEW 8-K →
GXO08:57 ETneutral
GXO Logistics, Inc. (GXO) quarterly results
The company announced its 2030 financial targets and preliminary 2027 outlook, but the information is forward-looking and subject to various risks and uncertainties, and no quantified surprises are disclosed.
OUR ANALYSIS → VIEW 8-K →
IBATF08:05 ETnegative
INTERNATIONAL BATTERY METALS LTD. (IBATF) quarterly results
The company's Q2 fiscal 2027 results show a net income of $2.2 million, but revenue is $0.0, and they plan to enter into a secured term loan of up to $12.0 million, which may indicate dilution. The pilot plant development and potential deployments are positives, but the lack of significant revenue and reliance on bridge financing are concerns.
OUR ANALYSIS → VIEW 8-K →
APMD08:04 ETneutral
Apnimed, Inc. (APMD) quarterly results
The company's cash position of $351.8 million and advancing commercial readiness activities are positives, but the lack of a quantified surprise in earnings or guidance may limit upside, and the recent IPO dilution could still be a factor in investor sentiment.
OUR ANALYSIS → VIEW 8-K →
JSPR08:00 ETneutral
Jasper Therapeutics, Inc. (JSPR) quarterly results
The company reported progress in its development programs, including the completion of enrollment in the first cohort of its Phase 2 renal basket study, and announced a private placement resulting in gross proceeds of approximately $132.0 million, but also underwent a 1-for-30 reverse stock split, which may indicate dilution and financial pressure
OUR ANALYSIS → VIEW 8-K →
ELA17:31 ETpositive
Envela Corp (ELA) quarterly results
Envela Corp reported quarterly revenue of $43.4 million and quarterly earnings per diluted share of $0.15, with operating income growing 11.5% to $4.7 million and gross margin expanding to 29.4% of revenue, driven by a favorable sales mix and improved Consumer segment gross margin.
OUR ANALYSIS → VIEW 8-K →
VJET17:29 ETpositive
Flyte Aviation, Inc. (VJET) quarterly results
Flyte Aviation reports record quarterly revenue of $1,838,000, a 145% sequential increase, with total flight hours surging 129% and aircraft utilization exceeding 99%, but the stock's recent trading history shows a 46% decline over the past month, which may impact investor sentiment.
OUR ANALYSIS → VIEW 8-K →
XBP17:22 ETnegative
XBP Global Holdings, Inc. (XBP) quarterly results
XBP Global Holdings, Inc. reported a net loss of $89.0 million, including a goodwill impairment charge of $68.4 million, and revenue declined 12.6% year-over-year, but the company saw a 204.8% increase in total TCV bookings and raised its target for annualized operational efficiencies to $70 million to $75 million. The company also completed a private placement of approximately 2.3 million shares
OUR ANALYSIS → VIEW 8-K →
BENF17:20 ETneutral
Beneficient (BENF) quarterly results
The company reported progress on eliminating purported debt, closed a $7.4 million GP Primary Capital transaction, and announced plans to launch an alternative asset portfolio analytics platform, while also reducing operating expenses and improving liquidity. However, the stock's recent trading history and the lack of a significant positive surprise suggest caution.
OUR ANALYSIS → VIEW 8-K →
LFT17:20 ETneutral
Lument Finance Trust, Inc. (LFT) quarterly results
Lument Finance Trust reported a GAAP net loss of $13.5 million and a non-GAAP distributable loss of $0.7 million for the third quarter, with no quantified positive surprise to drive a price move, and the filing does not indicate any significant events that would impact the stock price in the short term.
OUR ANALYSIS → VIEW 8-K →
SPAI17:12 ETpositive
Safe Pro Group Inc. (SPAI) quarterly results
Safe Pro Group Inc. reported record Q3 revenue of $2.68 million, up 2,539% year-over-year, with a record 79% AI gross margin and net loss narrowing 69% to $(0.08) per share, also announcing its first U.S. Army prime contract for AI threat detection onboard the Anduril Ghost-X drone
OUR ANALYSIS → VIEW 8-K →
ONEN17:11 ETnegative
ONE Nuclear Energy Inc. (ONEN) quarterly results
The company's recent 8-K filing reports its third quarter and year-to-date 2026 financial results, with a focus on its differentiated infrastructure strategy and multi-gigawatt development pipeline, but lacks quantified surprises or significant positive news, and the New Circle Forward Purchase Agreement may lead to dilution
OUR ANALYSIS → VIEW 8-K →
NDRA17:04 ETnegative
ENDRA Life Sciences Inc. (NDRA) quarterly results
ENDRA Life Sciences reports a net loss of $1.5 million for the third quarter of 2026 and announces a proposed merger with Noble Africa, which includes a concurrent private placement expected to result in $50 million in gross proceeds, but the company's cash position is limited with only $1.5 million in unrestricted cash, and the transaction is subject to customary closing conditions, including sto
OUR ANALYSIS → VIEW 8-K →
CUE16:52 ETpositive
Cue Biopharma, Inc. (CUE) quarterly results
Cue Biopharma reported positive Phase 2 results for CUE-221, demonstrating statistically significant improvements in chronic spontaneous urticaria, and initiated first-in-human dosing for CUE-401, but the filing lacks specific quantified surprises or financial guidance, making the impact uncertain, though the clinical progress is a positive development for the company.
OUR ANALYSIS → VIEW 8-K →
BALY16:22 ETpositive
Bally's Corp (BALY) quarterly results
Bally's Corp reported a 21.7% year-over-year increase in consolidated revenue to $807.6 million, driven by strong growth in Bally's Intralot B2C and North America Interactive segments, and announced the closure of a $400 million term loan to fund its Bally's Bronx project, with an additional $160 million in delayed-draw commitments
OUR ANALYSIS → VIEW 8-K →
VIP16:20 ETneutral
Vulcan Infrastructure & Power Inc. (VIP) quarterly results
The company announced the completion of a $39.3 million strategic investment and the redemption of its 2026 Senior Notes, which strengthens its financial position and supports its AI/HPC infrastructure growth strategy, but the filing lacks specific quantified surprises or guidance beats to warrant a positive impact call.
OUR ANALYSIS → VIEW 8-K →
FIRY16:19 ETpositive
Firy Inc. (FIRY) quarterly results
Firy Inc. reported a 14% year-over-year revenue increase to $31.3 million and a net loss of $12.5 million, with adjusted EBITDA loss of $1.2 million, excluding litigation expense. The company's cash and cash equivalents were $71.0 million as of September 30, 2026, and they received $55 million from the sale of their Exit Games stake and redeemed $49.7 million of senior secured notes in October.
OUR ANALYSIS → VIEW 8-K →
AYTU16:17 ETpositive
AYTU BIOPHARMA, INC (AYTU) quarterly results
The company announced a definitive merger agreement with Rosemont Pharmaceuticals Holdings, Inc. to be acquired for $2.70 per share in cash, representing total consideration of approximately $56 million, and reported fiscal 2027 first quarter operational and financial results with net revenue increasing 6.9% to $14.8 million.
OUR ANALYSIS → VIEW 8-K →
RDI15:27 ETpositive
READING INTERNATIONAL INC (RDI) quarterly results
Reading International reports a significant improvement in Q3 2026 results, with total revenues increasing by 25% and operating income turning positive at $6.1 million, driven by strong box office performance and execution of strategic operating initiatives. The company's improved results and positive outlook, combined with debt repayment and reduced general and administrative costs, are notable p
OUR ANALYSIS → VIEW 8-K →
DTST09:30 ETneutral
Data Storage Corp (DTST) quarterly results
Data Storage Corporation reported $9.5 million in cash and marketable securities with no long-term debt, and a 4.3% increase in third-quarter revenue, but lacks a significant quantified surprise to drive a substantial price move
OUR ANALYSIS → VIEW 8-K →
JAGX09:15 ETneutral
Jaguar Health, Inc. (JAGX) quarterly results
Jaguar Health reported a reduced net loss of $5.83 million in Q3 2026, with total revenue decreasing 24% year-over-year to $2.34 million, and the company significantly reduced its outstanding debt balance by $10.1 million during the quarter.
OUR ANALYSIS → VIEW 8-K →
SWRD09:13 ETneutral
Stewards, Inc. (SWRD) quarterly results
The company reported a net loss of $19.4 million and total assets increased 49% to $265.3 million, but the filing lacks specific quantified surprises that would significantly impact the stock price beyond routine news.
OUR ANALYSIS → VIEW 8-K →
ELOX09:02 ETneutral
Eloxx Pharmaceuticals, Inc. (ELOX) quarterly results
Eloxx Pharmaceuticals reported Q3 financial results and a business update, including dosing the first two patients in the global Phase 2b EXACT study and finalizing the protocol for the Phase 2 EXPRESS study, with cash and cash equivalents of $56.3 million as of September 30, 2026. No significant quantified surprises were disclosed in the filing.
OUR ANALYSIS → VIEW 8-K →
AIMD08:41 ETpositive
Ainos, Inc. (AIMD) quarterly results
Ainos reported a significant revenue increase of 29,567% year over year to $642,889 and a narrower net loss, driven by VELDONA licensing and AI Nose semiconductor programs, with a follow-on $9 million order secured subsequent to quarter-end.
OUR ANALYSIS → VIEW 8-K →
USDE08:35 ETneutral
StableCoinX Inc. (USDE) quarterly results
StablecoinX reported a significant revenue increase of 666% to $477,993 in the third quarter, driven by its Decentralized Verifier Node infrastructure services business, and its ENA treasury is now fully unlocked with approximately 3.0 billion tokens, but the company still posted a net loss of $100.2 million, primarily due to non-cash losses associated with warrant liabilities and note extinguishm
OUR ANALYSIS → VIEW 8-K →
APVO08:35 ETpositive
Aptevo Therapeutics Inc. (APVO) quarterly results
Aptevo Therapeutics reports a 79% remission rate for Mipletamig in high-risk TP53-mutated AML, nearly double the historical benchmark, and announces progress in optimizing treatment tolerability and advancing its next-generation cancer treatment pipeline.
OUR ANALYSIS → VIEW 8-K →
IPDN08:32 ETnegative
Professional Diversity Network, Inc. (IPDN) quarterly results
The company's third-quarter revenues decreased 48.2% year-over-year, and while they made progress in strengthening their working capital position and managing operating expenses, the lack of quantified positive surprises and significant revenue declines suggest a negative impact. The launch of their GPU computing initiative is a potential growth opportunity, but its impact is unclear and has not y
OUR ANALYSIS → VIEW 8-K →
DWSN08:13 ETnegative
DAWSON GEOPHYSICAL CO (DWSN) quarterly results
Dawson Geophysical reported a net loss of $5.2 million and negative Adjusted EBITDA of $2 million for the third quarter, missing expectations, but CEO Tony Clark expressed excitement about the company's positioning for renewed demand in seismic data acquisition services in North America, with a strengthened backlog of contracted jobs and increasing demand from major oil and gas companies, which co
OUR ANALYSIS → VIEW 8-K →
VERI08:12 ETnegative
Veritone, Inc. (VERI) quarterly results
Veritone's Q3 revenue and Annual Recurring Revenue (ARR) decreased by 30.1% and 12.6% year-over-year, respectively, and the company announced a debt exchange and commitment letter for new financing, but the debt exchange and need for additional financing may indicate covenant pressure and dilution
OUR ANALYSIS → VIEW 8-K →
ALXO08:10 ETneutral
ALX ONCOLOGY HOLDINGS INC (ALXO) quarterly results
The company reported Q3 financial results with cash and equivalents of $147.2 million, which is expected to fund operations through the first half of 2028, and announced expectations for topline data from clinical trials, including the ASPEN-09-Breast trial in 2H 2027 and ALX2004 Phase 1 trial data in December 2026.
OUR ANALYSIS → VIEW 8-K →
IAM08:08 ETpositive
Iambic Therapeutics, Inc. (IAM) quarterly results
Iambic Therapeutics reported strong Q3 financial results, including $24 million in collaboration revenue and a cash position of $252 million, with a pro-forma cash position of $455 million after their IPO and AbbVie upfront payments. The company also announced positive clinical data for its IAM1363 candidate and plans to initiate a registrational study in 2027.
OUR ANALYSIS → VIEW 8-K →
NMRA08:03 ETnegative
Neumora Therapeutics, Inc. (NMRA) quarterly results
Neumora Therapeutics reported a net loss of $34.4 million for the third quarter of 2026 and announced the submission of its IND for NMRA-215, but also noted that it will require substantial additional funding to continue operating, which may not be available on favorable terms. The company's cash position was $85.7 million as of September 30, 2026.
OUR ANALYSIS → VIEW 8-K →
ADGM08:02 ETnegative
Adagio Medical Holdings, Inc. (ADGM) quarterly results
Adagio Medical reported a net income of $17.8 million for the third quarter, primarily driven by a noncash gain related to the change in fair value of its Senior Secured Convertible Notes, and announced a formal process to explore strategic alternatives to maximize shareholder value, but cash and cash equivalents were only $3.1 million as of September 30, 2026
OUR ANALYSIS → VIEW 8-K →
POWW08:00 ETpositive
Outdoor Holding Co (POWW) quarterly results
The company reported a 14.6% increase in revenue and a 63.6% increase in net income from continuing operations, with adjusted EBITDA growing 24.7% year-over-year, demonstrating strong execution of its strategy and gaining market share.
OUR ANALYSIS → VIEW 8-K →
MNTK07:45 ETnegative
Montauk Renewables, Inc. (MNTK) quarterly results
Montauk Renewables reported a 10.9% year-over-year increase in revenues to $50.2 million, but net income decreased 58.9% to $2.1 million, and the company is seeking to amend its senior credit facility to borrow additional debt and temporarily forbear certain debt covenant requirements, which may indicate covenant pressure and potential dilution
OUR ANALYSIS → VIEW 8-K →
MPLT07:20 ETneutral
MapLight Therapeutics, Inc. (MPLT) quarterly results
MapLight Therapeutics reported a strong cash position of $463.4 million, which is expected to fund operations through key clinical readouts and through 2028, and announced plans to advance ML-007C-MA into a Phase 3 trial for schizophrenia and a Phase 2 trial for Alzheimer's disease psychosis, but no quantified surprises were disclosed in the filing.
OUR ANALYSIS → VIEW 8-K →
GNLN16:50 ETneutral
Greenlane Holdings, Inc. (GNLN) quarterly results
Greenlane Holdings reported a net income of $4.4 million for Q3 2026, driven by a $4.5 million non-cash fair value gain on digital assets and a $3.1 million non-cash gain on deconsolidation of legacy subsidiaries, with BERA-per-share increasing approximately 13% from year-end.
OUR ANALYSIS → VIEW 8-K →
IVF10:30 ETpositive
INVO Fertility, Inc. (IVF) quarterly results
INVO Fertility reported a 28% increase in clinic revenue and its seventh consecutive quarter of positive Clinic-Level Adjusted EBITDA, with a narrowing net loss and improving balance sheet, driven by organic and acquired growth, and clinic efficiency initiatives.
OUR ANALYSIS → VIEW 8-K →
RPID10:17 ETpositive
RAPID MICRO BIOSYSTEMS, INC. (RPID) quarterly results
The company announced its Q3 financial results and is being acquired by Merck KGaA, but the tender offer has not yet commenced, and the acquisition is subject to various closing conditions and risks.
OUR ANALYSIS → VIEW 8-K →
UNCY09:28 ETneutral
Unicycive Therapeutics, Inc. (UNCY) quarterly results
The FDA's acceptance of Unicycive Therapeutics' New Drug Application (NDA) resubmission for oxylanthanum carbonate (OLC) with a PDUFA target action date of March 25, 2027, is a positive development, and the company's cash runway beyond 2027 provides financial stability. However, this news is likely already priced in, given the previous announcement of the NDA acceptance in October.
OUR ANALYSIS → VIEW 8-K →
TOON09:00 ETneutral
Kartoon Studios, Inc. (TOON) quarterly results
Kartoon Studios reported $33 million in cash and marketable securities, and announced agreements with Walmart Marketplace and Amazon Prime to launch Hundred Acre Wood streaming and consumer products, but the filing lacks quantified surprises or significant positive news beyond operational updates.
OUR ANALYSIS → VIEW 8-K →
HTCR08:28 ETnegative
HeartCore Enterprises, Inc. (HTCR) quarterly results
HeartCore Enterprises reported a significant decline in revenues and a net loss for the third quarter, with revenues of $162,000 compared to $1.2 million in the same period last year, and a net loss of $596,000 compared to net income of $351,000 in the same period last year.
OUR ANALYSIS → VIEW 8-K →
XTND07:19 ETpositive
Xtend AI Robotics, Inc. (XTND) quarterly results
XTND reports a significant 281% year-over-year revenue increase to $14.9 million, with a substantial funded backlog of $100.7 million in its AI Robotics segment, indicating strong growth prospects. The company's nine-month revenue has already surpassed its full-year 2025 revenue, suggesting a positive trend.
OUR ANALYSIS → VIEW 8-K →
CNTN08:35 ETpositive
Canton Strategic Holdings, Inc. (CNTN) quarterly results
Canton Strategic Holdings, Inc. reported a 104% increase in total revenue to $3 million and achieved its first positive quarterly Adjusted EBITDA of $610,414, but also reported a significant net loss of $35 million. The company's operating expenses increased by only 0.5%, and its Adjusted Operating Expenses Coverage Ratio rose to 112.6% from 56.9% in the prior quarter.
OUR ANALYSIS → VIEW 8-K →
ACCV08:04 ETneutral
Accelevation Holdings Corp. (ACCV) quarterly results
The company corrected errors in its previously reported quarterly earnings, but the corrections did not change the financial statements or non-GAAP financial measures, and the updated press release still shows strong revenue growth and robust cash generation.
OUR ANALYSIS → VIEW 8-K →
TRAW16:45 ET
Traws Pharma, Inc. (TRAW) quarterly results
Filed — our read is on its way.
VIEW 8-K →
AMCI16:42 ET
AMC Robotics Corp (AMCI) quarterly results
Filed — our read is on its way.
VIEW 8-K →
BAER16:40 ET
Bridger Aerospace Group Holdings, Inc. (BAER) quarterly results
Filed — our read is on its way.
VIEW 8-K →
TOPP16:40 ET
Toppoint Holdings Inc. (TOPP) quarterly results
Filed — our read is on its way.
VIEW 8-K →
WRAP16:40 ET
WRAP TECHNOLOGIES, INC. (WRAP) quarterly results
Filed — our read is on its way.
VIEW 8-K →
AIDX16:39 ET
20/20 Biolabs, Inc. (AIDX) quarterly results
Filed — our read is on its way.
VIEW 8-K →
MLP16:36 ET
MAUI LAND & PINEAPPLE CO INC (MLP) quarterly results
Filed — our read is on its way.
VIEW 8-K →
CVU16:34 ET
CPI AEROSTRUCTURES INC (CVU) quarterly results
Filed — our read is on its way.
VIEW 8-K →
16:34 ET
CubeSmart, L.P. quarterly results
Filed — our read is on its way.
VIEW 8-K →
MDIA16:33 ET
Mediaco Holding Inc. (MDIA) quarterly results
Filed — our read is on its way.
VIEW 8-K →
HYFM16:33 ET
HYDROFARM HOLDINGS GROUP, INC. (HYFM) quarterly results
Filed — our read is on its way.
VIEW 8-K →
POCI16:30 ET
PRECISION OPTICS CORPORATION, INC. (POCI) quarterly results
Filed — our read is on its way.
VIEW 8-K →
GPUS16:30 ET
Hyperscale Data, Inc. (GPUS) quarterly results
Filed — our read is on its way.
VIEW 8-K →
POWL16:24 ET
POWELL INDUSTRIES INC (POWL) quarterly results
Filed — our read is on its way.
VIEW 8-K →
AEON16:16 ET
AEON Biopharma, Inc. (AEON) quarterly results
Filed — our read is on its way.
VIEW 8-K →
BCLI16:16 ET
BRAINSTORM CELL THERAPEUTICS INC. (BCLI) quarterly results
Filed — our read is on its way.
VIEW 8-K →
AQMS16:16 ET
Aqua Metals, Inc. (AQMS) quarterly results
Filed — our read is on its way.
VIEW 8-K →
SHAZ16:15 ET
SharonAI Holdings Inc. (SHAZ) quarterly results
Filed — our read is on its way.
VIEW 8-K →
STEM16:13 ET
STEM, INC. (STEM) quarterly results
Filed — our read is on its way.
VIEW 8-K →
GETYQ16:12 ET
Getty Images Holdings, Inc. (GETYQ) quarterly results
Filed — our read is on its way.
VIEW 8-K →
LUVU16:12 ET
Luvu Brands, Inc. (LUVU) quarterly results
Filed — our read is on its way.
VIEW 8-K →
CNTB16:11 ET
Connect Biopharma Holdings Ltd (CNTB) quarterly results
Filed — our read is on its way.
VIEW 8-K →
INFQ16:11 ET
Infleqtion, Inc. (INFQ) quarterly results
Filed — our read is on its way.
VIEW 8-K →
ACM16:11 ET
AECOM (ACM) quarterly results
Filed — our read is on its way.
VIEW 8-K →
LCTC16:10 ET
Lifeloc Technologies, Inc (LCTC) quarterly results
Filed — our read is on its way.
VIEW 8-K →
RDZN16:10 ET
Roadzen Inc. (RDZN) quarterly results
Filed — our read is on its way.
VIEW 8-K →
ORIC16:10 ET
Oric Pharmaceuticals, Inc. (ORIC) quarterly results
Filed — our read is on its way.
VIEW 8-K →
ENTA16:10 ET
ENANTA PHARMACEUTICALS INC (ENTA) quarterly results
Filed — our read is on its way.
VIEW 8-K →
OMER16:10 ET
OMEROS CORP (OMER) quarterly results
Filed — our read is on its way.
VIEW 8-K →
IDAI16:07 ET
T Stamp Inc (IDAI) quarterly results
Filed — our read is on its way.
VIEW 8-K →
TMS16:07 ET
Teamshares Inc (TMS) quarterly results
Filed — our read is on its way.
VIEW 8-K →
GPRO16:07 ET
GoPro, Inc. (GPRO) quarterly results
Filed — our read is on its way.
VIEW 8-K →
LONA16:07 ET
LeonaBio, Inc. (LONA) quarterly results
Filed — our read is on its way.
VIEW 8-K →
RCAT16:06 ET
Red Cat Holdings, Inc. (RCAT) quarterly results
Filed — our read is on its way.
VIEW 8-K →
SMID16:06 ET
SMITH MIDLAND CORP (SMID) quarterly results
Filed — our read is on its way.
VIEW 8-K →
WKHS16:06 ET
Workhorse Group Inc. (WKHS) quarterly results
Filed — our read is on its way.
VIEW 8-K →
NXB16:05 ET
NextBoat Inc. (NXB) quarterly results
Filed — our read is on its way.
VIEW 8-K →
BRFH16:05 ET
BARFRESH FOOD GROUP INC. (BRFH) quarterly results
Filed — our read is on its way.
VIEW 8-K →
EUBG16:05 ET
ENTREPRENEUR UNIVERSE BRIGHT GROUP (EUBG) quarterly results
Filed — our read is on its way.
VIEW 8-K →
ACRV16:05 ET
Acrivon Therapeutics, Inc. (ACRV) quarterly results
Filed — our read is on its way.
VIEW 8-K →
KYNB16:05 ET
KYNTRA BIO, INC. (KYNB) quarterly results
Filed — our read is on its way.
VIEW 8-K →
DARE16:02 ET
Dare Bioscience, Inc. (DARE) quarterly results
Filed — our read is on its way.
VIEW 8-K →
SLNH16:01 ET
Soluna Holdings, Inc (SLNH) quarterly results
Filed — our read is on its way.
VIEW 8-K →
EP16:01 ET
EMPIRE PETROLEUM CORP (EP) quarterly results
Filed — our read is on its way.
VIEW 8-K →
IMDX16:00 ET
Insight Molecular Diagnostics Inc. (IMDX) quarterly results
Filed — our read is on its way.
VIEW 8-K →
CREX07:45 ET
CREATIVE REALITIES, INC. (CREX) quarterly results
Filed — our read is on its way.
VIEW 8-K →
TSN07:41 ET
TYSON FOODS, INC. (TSN) quarterly results
Filed — our read is on its way.
VIEW 8-K →
EDBL07:35 ET
Edible Garden AG Inc (EDBL) quarterly results
Filed — our read is on its way.
VIEW 8-K →
VIDA07:35 ET
VIDA Global Inc. (VIDA) quarterly results
Filed — our read is on its way.
VIEW 8-K →
MBRX07:30 ET
Moleculin Biotech, Inc. (MBRX) quarterly results
Filed — our read is on its way.
VIEW 8-K →
LRMR07:17 ET
Larimar Therapeutics, Inc. (LRMR) quarterly results
Filed — our read is on its way.
VIEW 8-K →
PRLD07:09 ET
Prelude Therapeutics Inc (PRLD) quarterly results
Filed — our read is on its way.
VIEW 8-K →
IVVD07:08 ET
Invivyd, Inc. (IVVD) quarterly results
Filed — our read is on its way.
VIEW 8-K →
CYPH07:05 ET
CYPHERPUNK TECHNOLOGIES INC. (CYPH) quarterly results
Filed — our read is on its way.
VIEW 8-K →
XTNT07:05 ET
Xtant Medical Holdings, Inc. (XTNT) quarterly results
Filed — our read is on its way.
VIEW 8-K →
AIRJ07:05 ET
AirJoule Technologies Corp. (AIRJ) quarterly results
Filed — our read is on its way.
VIEW 8-K →
MTRI07:03 ET
InMed Pharmaceuticals Inc. (MTRI) quarterly results
Filed — our read is on its way.
VIEW 8-K →
LXEO07:02 ET
Lexeo Therapeutics, Inc. (LXEO) quarterly results
Filed — our read is on its way.
VIEW 8-K →
ELWT07:00 ET
Elauwit Connection, Inc. (ELWT) quarterly results
Filed — our read is on its way.
VIEW 8-K →
TIL07:00 ET
Instil Bio, Inc. (TIL) quarterly results
Filed — our read is on its way.
VIEW 8-K →
VYCO06:58 ET
VYCOR MEDICAL INC (VYCO) quarterly results
Filed — our read is on its way.
VIEW 8-K →
BXDC06:46 ET
Blackstone Digital Infrastructure Trust Inc. (BXDC) quarterly results
Filed — our read is on its way.
VIEW 8-K →
ARMK06:31 ET
Aramark (ARMK) quarterly results
Filed — our read is on its way.
VIEW 8-K →
ODYS06:20 ET
Odysight.ai Inc. (ODYS) quarterly results
Filed — our read is on its way.
VIEW 8-K →
QIND06:15 ET
Quality Industrial Corp. (QIND) quarterly results
Filed — our read is on its way.
VIEW 8-K →
XXII06:02 ET
22nd Century Group, Inc. (XXII) quarterly results
Filed — our read is on its way.
VIEW 8-K →
SLXN06:01 ET
Silexion Therapeutics Corp (SLXN) quarterly results
Filed — our read is on its way.
VIEW 8-K →
The results that matter, before the open
The material filings, RNS and EU notices in one email every market day, read and scored by AI.
Subscribe free →